Flibanserin, sold under the brand name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive sexual desire disorder (HSDD). The medication attempts to improve sexual desire, increase the number of satisfying sexual events, and decrease the distress associated with low sexual desire. The most common side effects are dizziness, sleepiness, nausea, difficulty falling asleep or staying asleep and dry mouth.
via Wikipedia infobox
via PubMed
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 437139289 | image = Flibanserin.svg | image_class = skin-invert-image | alt = | image2 = Flibanserin ball-and-stick model.png | image_class2 = bg-transparent | alt2 =
| pronounce = | tradename = Addyi | Drugs.com = | MedlinePlus = a615040 | DailyMedID = Flibanserin | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category = | routes_of_administration = By mouth | class = | ATC_prefix = G02 | ATC_suffix = CX02
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).